Glutamatergic and cholinergic-regulation of immediate-early gene and neuropeptide gene expression in the striatum

Pharmacological Regulation of Gene Expression in the CNS

Volumn , Issue , 2017, Pages 81-114

  Wang, John Q ^a   McGinty, Jacqueline F ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85054751261     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203711149     Document Type: Chapter

References (226)

1. 2 dopamine receptor-regulated gene expression of stri-atonigral and striatopallidal neurons, Science, 250, 1429, 1990.
2. Le Moine, C., Normand, E., Guitteny, A.F., Fouque, B., Teoule, R. and Bloch, B., Dopamine receptor gene expression by enkephalin neurons in rat forebrain, Proc. Natl Acad. Sci. U.S.A., 87, 230, 1990.
3. Le Moine, C. and Bloch, B., D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum, J. Comp. Neurol, 355, 418, 1995.
4. Cole, A. J., Bhat, R. V., Patt, C., Worley, P. F. and Baraban, J. M., Dj dopamine receptor activation of multiple transcription factor genes in rat striatum, J. Neurochem., 58, 1420, 1992.
5. Moratalla, R., Robertson, H. A. and Graybiel, A. M., Dynamic regulation of NGFI-A (zz/268, egrl) gene expression in the striatum, J. Neurosci., 12, 2609, 1992.
6. Sivam, S.P., Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism, J. Pharmacol. Exp. Ther., 250, 818, 1989.
7. Smiley, P.L., Johnson, M., Bush, L., Gibb, J.W. and Hanson, G.R., Effects of cocaine on extrapyramidal and limbic dynorphin systems, J. Pharmacol. Exp. Ther., 253, 938, 1990.
8. Surmeier, D.J., Reiner, A., Levine, M.S. and Ariano, M.A., Are neostriatal dopamine receptors co-localized?, TINS, 16, 299, 1993.
9. 2 dopamine receptor antagonists on acute amphetamine- or methamphetamine-induced upregulation of zif268 mRNA expression in rat striatum, J. Neurochem., 65, 2706, 1995.
10. 2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine and methamphetamine, Synapse, 22, 114, 1996.
11. 2 dopamine receptor blockade on zif268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge, Mol. Brain Res., 35, 237, 1996.
12. Bannon, M. J., Kelland, M. and Chiodo, L., Medial forebrain bundle stimulation or D-2 dopamine receptor activation increases preproenkephalin mRNA in rat striatum, J. Neurochem., 52, 859, 1989.
13. Hurd, Y. L. and Herkenham, M., Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides, Mol. Brain Res., 16, 97, 1992.
14. Steiner, H. and Gerfen, C. R., Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum, J. Neurosci., 13, 5066, 1993.
15. Hong, J. S., Yang, H. T. T., Gillin, J. C. and Costa, E., Effects of long-term administration of antipsychotic drugs on enkephalinergic neurons, Adv. Biochem. Psy-chopharmacol., 24, 223, 1980.
16. Young, W. S. Ill, Bonner, T. I. and Brann, M. R., Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain, Proc. Natl. Acad. Sci. U.S.A., 83, 9827, 1986.
17. Angulo, J.A., Cadet, J., Woolley, C., Suber, F. and McEwen, B., Effect of chronic typical and atypical neuroleptic treatment on proenkephalin mRNA levels in the striatum and nucleus accumbens of the rat, J. Neurochem., 54, 1889, 1990.
18. Augood, S. J., Faull, R. L. and Emson, R C., Contrasting effects of raclopride and SCH 23390 on the cellular content of proenkephalin A mRNA in rat striatum: a quantitative non-radioactive in situ hybridization study, Eur. J. Pharmacol, 4, 102, 1992.
19. Jiang, H. K., McGinty, J. F. and Hong, J. S., Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes, Brain Res., 507, 57, 1990.
20. Li, S. J., Jiang, H. K., Stachowiak, M. S., Hudson, P. M., Owyang, V., Nanry, K., Tilson, H. A. and Hong, J. S., Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum, Mol. Brain Res., 8, 219, 1990.
21. 20a. Di Chiara, G., Morelli, M. and Consolo, S., Modulatory functions of neurotransmitters in the striatum: Ach/dopamine/NMDA interactions, Trends Neurosci., 17, 228, 1994.
22. Dube, L., Smith, A. D. and Bolam, J. P., Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium size spiny neurons in the rat neostriatum, J. Comp. Neurol., 267, 455, 1988.
23. Frotscher, M., Rinner, U., Hassler, R. and Wagner, A., Termination of cortical afferents on identified neurons in the caudate nucleus of the cat: a combined Golgi-electron microscope degeneration study, Exp. Brain Res., 41, 329, 1981.
24. Smith, Y., Bennett, B. D., Bolam, J. P., Parent, A. and Sadikot, A. F., Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey, J. Comp. Neurol, 344, 1, 1994.
25. Somogyi, R, Bolam, J. P. and Smith, A. D., Monosynaptic cortical input and local axon collaterals of identified striatonigral neurons. A light and electron microscopic study using the Golgi-peroxidase transport-denegeration procedure, J. Comp. Neurol., 195, 567, 1981.
26. Lapper, S. R. and Bolam, J. R, Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat, Neuroscience, 51, 533, 1992.
27. Meredith, G. E. and Wouterlood, F. G., Hippocampal and midline thalamic fibres and terminals in relation to the choline acetyltransferase-immunoreactive neurons in nucleus accumbens of the rat: a light and electron microscopic study, J. Comp. Neurol., 296, 204, 1990.
28. Freund, T. F., Powell, J. F. and Smith, A. D., Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines, Neuroscience, 13, 1189, 1984.
29. Pickel, V. M., Chan, J. and Sesack, S. R., Cellular basis for interactions between catecholaminergic afferents and neurons containing Leu-enkephalin-like immu-noreactivity in rat caudate-putamen nuclei, J. Neurosci. Res., 31, 212, 1992.
30. Bouyer, J. J., Park, D. H., Joh, T. H. and Pickel, V. M., Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum, Brain Res., 302, 267, 1984.
31. Smith, A. D. and Bolam, J. R, The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons, TINS, 13, 259, 1990.
32. Sesack, S. R. and Pickel, V. M., In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other, Brain Res., 527, 266, 1990.
33. Totterdell, S. and Smith, A. D., Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat, J. Chem. Neu-roanat., 2, 285, 1989.
34. Monaghan, D., Bridages, R. and Cotman, C., The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system, Annu. Rev. Pharmacol. Toxicol., 29, 365, 1989.
35. Albin, R. L., Makowiec, R. L., Hollingsworth, Z. R., Dure IV, L. S., Penney, J. B. and Young, A. B., Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study, Neuroscience, 46, 35, 1992.
36. Greenamyre, J. T., Olsen, J. M. M, Penney, J. B. and Young, A. B., Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites, J. Pharmacol Exp. Ther., 233, 254, 1985.
37. Halpain, S., Wieczorek, C. M. and Rainbow, T. C., Localization of L-glutamate receptors in rat brain by quantitative autoradiography, J. Neurosci., 4, 2247, 1984.
38. 3H]glutamate binds to kainate-, NMDA-, and AMPA-sensitive binding sites: an autoradiographic analysis, Brain Res., 340, 378, 1985.
39. Greenamyre, J. T. and Young, A. B., Synaptic localization of striatal NMD A, quisqualate and kainate receptors, Neurosci. Lett., 101, 133, 1989.
40. 3H] Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding to rat striatal membranes: effects of selective brain lesions, J. Neurochem., 51, 579, 1988.
41. Wullner, U., Testa, C. M., Catania, M. V., Young, A. B. and Penney, J. B., Jr., Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions, Brain Res., 645, 98, 1994.
42. 3H]glutamic acid binding to rat striatal membranes. II. Effects of selective striatal lesions and deafferentations, Brain Res., 366, 178, 1986.
43. Roberts, P. J., McBean, G. J., Sharif, N. A., and Thomas, E. M., Striatal glutamater-gic function; modifications following specific lesions, Brain Res., 235, 83, 1982.
44. Tallaksen-Greene, S. J., Wiley, R. G. and Albin, R. L., Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons, Brain Res., 594, 165, 1992.
45. Norman, A. B., Ford, L. M., Kolmonpunporn, M. and Sanberg, P. R., Chronic treatment with MK-801 increases the quinolinic acid-induced loss of D-l dopamine receptors in rat striatum, Eur. J. Pharmacol., 176, 363, 1990.
46. Tallaksen-Greene, S. J. and Albin, R. L., Localization of AMPA-selective excitatory amino acid receptor subunits in identified population of striatal neurons, Neuroscience, 61, 509, 1994.
47. Nakanishi, S., Masu, M., Bessho, Y, Nakajima, Y., Hayashi, Y. and Shigemoto, R., Molecular diversity of glutamate receptors and their physiological functions, EXS, 71, 71, 1994.
48. Schoepfer, R., Monyer, H., Sommer, B., Wisden, W., Sprengel, R., Kuner, T., Lomeli, H., Herb, A., Kohler, M. and Burnashev, N., Molecular biology of glutamate receptors, Prog. Neurobiol., 42, 353, 1994.
49. Westbrook, G. L., Glutamate receptor subtypes, Curr. Opinion Neurobiol, 4, 337,1994.
50. Wisden, W. and Seeburg, P. H., Mammalian ionotropic glutamate receptors, Curr. Opinion Neurobiol, 3, 291, 1993.
51. Gall, C., Sumikawa, K. and Lynch, G., Levels of mRNA for a putative kainate receptor are affected by seizures, Proc. Natl. Acad. Sci. U.S.A., 87, 7643, 1990.
52. Pellegrini-Giampietro, D. E., Bennett, M. V. L. and Zukin, R. S., Differential expression of three glutamate receptor genes in developing rat brain: an in situ hybridization study, Proc. Natl. Acad. Sci. U.S.A., 88, 4157, 1991.
53. Sato, K., Kiyama, H. and Tohyama, M., The differential expression patterns of messenger RNAs encoding non-N-methyl-D-aspartate glutamate receptor subunits (GluRl-4) in the rat brain, Neuroscience, 52, 515, 1993.
54. Standaert, D. G., Testa, C. M., Young, A. B. and Penney, J. B., Jr., Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat, J. Comp. Neurol, 343, 1, 1994.
55. Landwehrmeyer, G. B., Standaert, D. G., Testa, C. M., Penney, J. B. and Young, A.B., NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum, J. Neurosci., 15, 5297, 1995.
56. Martin, L. J., Blackstone, C. D., Levey, A. I., Huganir, R. L. and Price, D. L., AMPA glutamate receptor subunits are differentially distributed in rat brain, Neuroscience, 53, 327, 1993.
57. Petralia, R. S. and Wenthold, R. J., Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain, J.Comp. Neurol., 318, 329, 1992.
58. Kendall, D. A., Direct and indirect responses to metabotropic glutamate receptor activation in the brain, Biochem. Soc. Transact., 21, 1120, 1993.
59. Schoepp, D. D. and Conn, P. J., Metabotropic glutamate receptors in brain function and pathology, TIPS, 14, 13, 1993.
60. Ohishi, H., Shigemoto, R., Nakanishi, S. and Mizuno, N., Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat, Neuroscience, 53, 1009, 1993.
61. Ohishi, H., Akazawa, C., Shigemoto, R., Nakankshi, S. and Mizuno, N., Distribution of the mRNAs for L-2-amino-4-phosphonobutyrate-sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in the rat brain, J. Comp. Neurol., 360, 555, 1995.
62. Shigemoto, R., Nakanishi, S. and Mizuno, N., Distribution of the mRNA for a metabotropic glutamate receptor (mGluRl) in the central nervous system: an in situ hybridization study in adult and developing rat, J. Comp. Neurol., 322, 121, 1992.
63. Tanabe, Y., Nomura, A., Masu, M., Shigemoto, R., Mizuno, N. and Nakanishi, S., Signal transduction, pharmacologic properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4, J. Neurosci., 13, 1372, 1993.
64. Testa, C. M., Standaert, D. G., Young, A. B. and Penney, J. B., Jr., Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat, J. Neurosci., 14, 3005, 1994.
65. Kinzie, J. M., Saugstad, J. A., Westbrook, G. L. and Segerson, T. P, Distribution of metabotropic glutamate receptor 7 messenger RNA in the developing and adult rat brain, Neuroscience, 69, 167, 1995
66. Martin, L. J., Blackstone, C. D., Huganir, R. L. and Price, D. L., Cellular localization of a metabotropic glutamate receptor in rat brain, Neuron, 9, 259, 1992.
67. Shigemoto, R., Nomura, S., Ohishi, H., Sugihara, H., Nakanishi, S. and Mizuno, N., Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain, Neurosci. Lett., 163, 53, 1993.
68. Fotuhi, M., Sharp, A. H., Glatt, C. E., Hwang, P. M., von Krosigk, M., Snyder, S. H. and Dawson, T. M., Differential localization of phosphoinositide-linked metabotropic glutamate receptor (mGluRl) and the inositol 1,4,5,-trisphosphate receptor in rat brain, J. Neurosci., 13, 2001, 1993.
69. Romano, C., Sesma, M. A., McDonald, C. T., O'Malley, K., Van Der Pol, A. N. and Olney, J. W., Distribution of metabotropic glutamate receptor mGluR5 immunore-activity in rat brain, J. Comp. Neurol., 355, 455, 1995.
70. Karler, R., Calder, L. D., Chaudhry, I. A. and Turkanis, S. A., Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801, Life Sci., 45, 599, 1989.
71. Karler, R., Chaudhry, I. A., Calder, L. D. and Turkanis, S. A., Amphetamine sensitization and the excitatory amino acids, Brian Res., 537, 76, 1990.
72. Stewart, J. and Druhan, J. R, The development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the noncompetitive NMDA receptor antagonist, MK-801, Psychopharmacology, 110,125, 1993.
73. Wolf, M. E. and Khansa, M. R., Repeated administration of MK-801 produces sensitization to its own locomotor stimulation effects but blocks sensitization to amphetamine, Brain Res., 562, 164, 1991.
74. Wolf, M. E. and Jeziorski, M., Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization, Brain Res., 613, 291, 1993.
75. Ohmori, T., Abekawa, A., Muraki, A. and Koyama, T., Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine, Pharmacol. Biochem. Behav., 48, 587, 1994.
76. Karler, R., Calder, L. D. and Bedingfield, J. B., Cocaine behavioral sensitization and the excitatory amino acids, Psychopharmacology, 115, 305, 1994.
77. Karler, R., Calder, L. D. and Turkanis, S. A., DNQX blockade of amphetamine behavioral sensitization, Brain Res., 552, 295, 1991.
78. Bristow, L. J., Thorn, L., Tricklebank, M. D. and Hutson, R H., Competitive NMDA receptor antagonists attenuate the behavioral and neurochemical effects of amphetamine in mice, Eur.]. Pharmacol, 264, 353, 1994.
79. Karler, R., Calder, L. D., Thai, L. H. and Bedingfield, J. B., A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine, Brain Res., 658, 8, 1994.
80. Witkin, J. M., Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists, Life Sci., 53, 405, 1993.
81. Hamilton, M. H., de Belleroche, J. S., Gardiner, I. M. and Herberg, L. J., Stimulatory effect of N-methyl-d-aspartate on locomotor activity and transmitter release from rat nucleus accumbens, Pharmacol. Biochem. Behav., 25, 943, 1986.
82. Karler, R., Calder, L. D., Thai, L. H. and Bedingfield, J. B., The dopaminergic, glutamatergic, GABAergic bases for the action of amphetamine and cocaine, Brain Res., 671, 100, 1995.
83. Kelley, A. E. and Throne, L. C, NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens, Brain Res. Bull., 29, 247,1992.
84. Pulvirenti, L., Swerdlow, N. R. and Koob, G. R, Microinjection of glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats, Neurosci. Lett., 103, 213, 1989.
85. Willins, D. L., Wallace, L. J., Miller, D. D. and Uretsky, N. J., a-Amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs, J. Pharmacol. Exp. Ther., 260, 1145, 1992.
86. Arnt, J., Hyperactivity following injection of a glutamate agonist and 6,7-ADTN into rat nucleus accumbens and its inhibition by THIP, Life Sci., 28, 1597, 1981.
87. Donzanti, B. A. and Uretsky, N. J., Antagonism of the hypermotility response induced by excitatory amino acids in the rat nucleus accumbens, Naunyn Schmiede-berge's Arch. Pharmacol., 325, 1, 1984.
88. Hooks, M. S. and Kalivas, P. W., Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity, J. Pharmacol. Exp. Ther., 269, 976, 1994.
89. Thanos, P. K., Jhamandas, K. and Beninger, R. J., N-methyl-D-aspartate unilaterally injected into the dorsal striatum of rats produces contralateral circling: antagonism by 2-amino-7-phosphonoheptamoic acid and cis-flupenthixol, Brain Res., 589, 55, 1992.
90. Sacaan, A. I., Monn, J. A. and Schoepp, D. D., Intrastriatal injection of a selective metabotropic excitatory amino acid receptor agonist induces contralateral turning in the rat, J. Pharmacol. Exp. Ther., 259, 1366, 1991.
91. Sacaan, A. I., Bymaster, F. P. and Schoepp, D. D., Metabotropic glutamate receptor activation produces extrapyramidal motor system activation that is mediated by striatal dopamine, J. Neurochem., 59, 245, 1992.
92. McDonald, J. W, Fix, A. S., Tizzano, J. P. and Schoepp, D. D., Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist, J. Neurosci., 13, 4445, 1993.
93. Nestler, E. J., Molecular neurobiology of drug addiction, Neuropsychopharmacology, 11, 77, 1994.
94. Johnson, M., Bush, L. G., Gibb, J. W. and Hanson, G. R. Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A system, Eur. J. Pharmacol, 193, 367, 1991.
95. Johnson, M., Bush, L. G., Gibb, J. W. and Hanson, G. R., Role of N-methyl-D-aspartate (NMDA) receptors in the response of extrapyramidal neurotension and dynorphin A system to cocaine and GBR 12909, Biochem. Pharmacol., 41, 649,1991.
96. Singh, N. A., Midgley, L. P., Bush, L. G., Gibb, J. W. and Hanson, G. R., N-Methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems, Brain Res., 555, 233, 1991.
97. Dragunow, M., Logan, B. and Laverty, R., 3,4-methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK-801, Eur. J. Pharmacol, 206, 255, 1991.
98. Ohno, M., Yoshida, H. and Watanabe, S., NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: relation to behavioral sensitization, Brain Res., 665, 135, 1994.
99. Snyder-Keller, A. M., Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena, Exp. Neurol, 113, 155, 1991.
100. Torres, G. and Rivier, C., Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists, Brain Res. Bull, 30, 173, 1993.
101. Cenci, M. A. and Bjorklund, A., Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behavioral in unilaterally 6-hydroxydopamine-lesioned rats, Eur. J. Neurosci., 5,1062,1993.
102. Fu, L. and Beckstead, R. M., Cortical stimulation induces Fos expression in striatal neurons, Neuroscience, 46, 329, 1992.
103. Smith, A. J. W. and McGinty, J. F., Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum, Mol. Brain Res., 21, 359, 1994.
104. Wang J. Q. and McGinty, J. F., Alterations in striatal zif268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats, Brain Res., 673, 262, 1995.
105. Wang J. Q. and McGinty, J. F., Dose-dependent alteration in zif268 and preprodynorphin mRNA expression induced by amphetamine and methamphetamine in rat forebrain, J. Pharmacol. Exp. Ther., 273, 909, 1995.
106. Wang J. Q., Smith, A. J. W. and McGinty, J. F., A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zz/268 and preprodynorphin mRNA expression in rat forebrain, Neuroscience, 68, 83, 1995.
107. Wang J. Q., Daunais, J. B. and McGinty, J. F., NMDA receptors mediate amphetamine-induced upregulation of zz/268 and preprodynorphin mRNA expression in rat striatum, Synapse, 18, 343, 1994.
108. Wang J. Q., Daunais, J. B. and McGinty, J. F., Role of kainate/AMPA receptors in induction of striatal zz/268 and preprodynorphin mRNA by a single injection of amphetamine, Mol. Brain Res. 27, 118, 1994.
109. Wang J. Q. and McGinty, J. F., Acute methamphetamine-induced zif268, preprodynorphin and preproenkephalin mRNA expression in rat striatum depends upon activation of NMDA and kainate/AMPA receptors, Brain Res. Bull, 39, 349, 1996.
110. Berretta, S., Robertson, H. A. and Graybiel, A. M., Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum, J. Neurophysiol., 68, 767, 1992.
111. Page, K. J. and Everitt, B. J., Transynaptic induction of c-fos in basal forebrain, diencephalic and midbrain neurons following AMPA-induced activation of the dorsal and ventral striatum, Exp. Brain Res., 93, 399, 1993.
112. Vaccarino, F. M., Hayward, M. D., Nestler, E. J., Duman, R. S. and Tallman, J. F., Differential induction of immediate early genes by excitatory amino acid receptor types in primary cultures of cortical and striatal neurons, Mol. Brain Res., 12, 233, 1992.
113. Beckstead, R. M., N-Methyl-D-aspartate acutely increases proenkephalin mRNA in the rat striatum, Synapse, 21, 342, 1995.
114. 5 enkephalin biosynthesis in neurons of the rat striatum, J. Pharmacol. Exp. Ther., 262, 823, 1992.
115. 5enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence, Mol. Brain Res., 8, 143, 1990.
116. Uhl, G. R., Navia, B. and Douglass, J., Differential expression of preproenkephalin and preprodynorphin mRNAs in striatal neurons: high levels of preproenkephalin expression depend on cerebral cortical afferents, J. Neurosci. 8, 4755, 1988.
117. Wang J. Q. and McGinty, J. F., Striatal metabotropic glutamate receptors regulate acute amphetamine-stimulated neuropeptide gene expression in the rat striatum, Soc. Neurosci. Abstr. in press.
118. Augood, S. J., Westmore, K., Faull, R. L. M. and Emson, P. C., Neuroleptics and striatal neuropeptide gene expression, Prog. Brain Res., 99, 181, 1993.
119. Ziolkowska, B. and Hollt, V., The NMD A receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum, Neurosci. Lett., 156, 39, 1993.
120. Cooper, A. J., Wooller, S. and Mitchell, I. J., Elevated striatal Fos immunoreactivity following 6-hydroxydopamine lesioning of the rat is mediated by excitatory amino acid transmission, Neurosci. Lett., 194, 73, 1995.
121. Hagihara, K., Tsumoto, T., Sato, H. and Hata, Y., Actions of excitatory amino acid antagonists on geniculo-cortical transmission in the cat's visual cortex, Lxp. Brain Res., 69, 407, 1988.
122. Miller, K. D., Chapman, B. and Stryker, M. P., Visual responses in adult cat visual cortex depend on N-methyl-D-aspartate receptor, Proc. Natl. Acad. Sci. U.S.A., 86, 5183, 1989.
123. Garcia-Munoz, M., Young, S. J. and Groves, P. M., Terminal excitability of the corticostriatal pathway. II. Regulation by glutamate receptor stimulation, Brain Res., 551, 207, 1991.
124. Worley, P. F., Christy, B. A., Nakabeppu, Y., Bhat, R. V., Cole, A. J. and Baraban, J. M., Constitutive expression of zif268 in neocortex is regulated by synaptic activity, Proc. Natl. Acad. Sci. U.S.A., 88, 5106, 1991.
125. Freed, W. J., Glutamatergic mechanisms mediating stimulant and antipsychotic drug effects, Neurosci. Biobehav. Rev., 18, 111, 1994.
126. Yamamoto, B. K. and Davy, S., Dopaminergic modulation of glutamate release in striatum as measured by microdialysis, J. Neurochem., 58, 1736, 1992.
127. Clow, D. W. and Jhamandas, K., Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen, J. Pharmacol. Exp. Ther., 248, 722, 1989.
128. Kalivas, P. W. and Duffy, P, Dj receptors modulate glutamate transmission in the ventral tegmental area, J. Neurosci., 15, 5379, 1995.
129. Reid, M. S., Herrera-Marschitz, M., Kehr, J. and Ungerstedt, U., Striatal dopamine and glutamate release: effects of intranigral injections of substance P, Acta Physiol. Scand., 140, 527, 1990.
130. Expósito, L, Sanz, B. Porras, A. and Mora, E, Effects of apomorphine and l-methionine sulphoximine on the release of excitatory amino acid neurotransmitters and glutamine in the striatum of the conscious rat, Eur.J. Neurosci., 6,287,1994.
131. Mora, F. and Porras, A., Effects of amphetamine on the release of excitatory amino acid neurotransmitters in the basal ganglia of the conscious rat, Can.J. Physiol. Pharmacol, 71, 348, 1993.
132. Smith, J. A., Mo, Q., Guo, H., Kunko, P. M. and Robinson, S. E, Cocaine increases extraneuronal levels of aspartate and glutamate in the nucleus accumbens, Brain Res., 683, 264, 1995.
133. Nash, J. F. and Yamamoto, B. K., Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methlenedioxymethamphetamine, Brain Res., 581, 237, 1992.
134. Nash, J. F. and Yamamoto, B. K., Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats, Brain Res., 627, 1, 1993.
135. Wang Z. and Rebec, G. V., Neuronal and behavioral correlates of intrastriatal infusions of amphetamine in freely moving rats, Brain Res., 627, 79, 1993.
136. Keefe, K. A., Zigmond, M. J. and Abercrombie, E. D., Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input, Neuroscience, 47, 325, 1992.
137. Martinez-Fong, D., Rosales, M. G., Gongora-Alfaro, J. L., Hernandez, S. and Ace ves, J., NMD A receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis, Brain Res., 595, 309, 1992.
138. Moghaddam, B., Gruen, R. J., Roth, R. H., Bunney, B. S. and Adams, R. N., Effect of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies, Brain Res., 518, 55, 1990.
139. Morari, M., O'Connor, W. T., Ungerstedt, U. and Fuxe, K., N-methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthetized rat: an in vivo microdialysis study, J. Neurochem., 60, 1884, 1993.
140. Morari, M., O'Connor, W. T., Ungerstedt, U. and Fuxe, K., Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid, Eur. J. Pharmacol, 256, 23, 1994.
141. Moghaddam, B. and Bolinao, M. L., Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implication for tonic influence of glutamate on dopamine release, Synapse, 18, 337,1994.
142. Pap, A. and Bradberry, C. W., Excitatory amino acid antagonists attenuate the effects of cocaine on extracellular dopamine in the nucleus accumbens, J. Pharmacol. Exp. Then, 274, 127, 1995.
143. Weihmuller, F. B., O'Dell, S. J., Cole, B. N. and Marshall, J. E, MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study, Brain Res., 549, 230, 1991.
144. 142a. Keefe, K.A., Zigmond, M.J. and Abercombie, E.D., In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids, J. Neural. Trans., 91, 223, 1993.
145. Kawaguchi, Y, Wilson, C. J., Augood, S. J. and Emson, P. C., Striatal interneurons: chemical, physiological and morphological characterization, TINS, 18, 527, 1995.
146. Yelnik, J., Percheron, G., Francois, C. and Gamier, A., Cholinergic neurons of the rat and primate striatum are morphologically different, Prog. Brain Res., 99, 25, 1993.
147. Bolam, J. P, Wainer, B. H. and Smith, A. D., Characterization of cholinergic neurons in the rat neostriatum. A combination of choline acetyltransferase immuno-cytochemistry, Golgi impregnation and electron microscopy, Neuroscience, 12, 711, 1984.
148. Phelps, P. E., Houser, C. R. and Vaughn, J. E., Immunocytochemical localization of choline acetyltransferase within the rat neostriatum: a correlated light and electron microscopic study of cholinergic neurons and synapses, J. Comp. Neurol, 238, 286, 1985.
149. Graybiel, A. M., Baugham, R. W. and Eckenstein, F., Cholinergic neuropil of the striatum observes striosomal boundaries, Nature, 323, 1986.
150. Lauterborn, J. C., Isackson, P. J., Montalvo, R. and Gall, C. M., In situ hybridization localization of choline acetyltransferase mRNA in adult rat brain and spinal cord, Mol. Brain Res., 17, 59, 1993.
151. Meredith, G. E., Blank, B. and Groenwegen, H. J., The distribution and compart-mental organization of the cholinergic neurons in nucleus accumbens of the rat, Neuroscience, 31, 327, 1989.
152. Izzo, P. N. and Bolam, J. P, Cholinergic synaptic input to different parts of spiny striatonigral neurons in the rat, J. Comp. Neurol, 269, 219, 1988.
153. Chang, H. T., Dopamine-acetylcholine interaction in the rat striatum: a dual-labeling immunocytochemical study, Brain Res. Bull, 21, 295, 1988.
154. Dimova, R., Vullet, J., Nieoullon, A. and Goff, L. K. L., Ultrastructural features of the choline acetyltransferase-containing neurons and relationship with nigral dopaminergic and cortical afferent pathways in the rat striatum, Neuroscience, 53, 1059, 1993.
155. Lapper, S. R. and Bolam, J. P, Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of rat, Neuroscience, 51, 533, 1992.
156. Meredith G. E. and Wouterlood F. G., Hippocampal and midline thalamic fibres and terminals in relation to the choline acetyltransferase-immunoreactive neurons in nucleus accumbens of the rat: a light and electron microscopic study, J. Comp. Neurol, 296, 204, 1990.
157. 2 and substance P (neurokinin-1) receptor messenger RNAs by a subpopulation of cholinergic neurons in the rat striatum, Neuroscience, 53, 417, 1993.
158. 2 dopamine receptor gene expressed by cholinergic neurons in the rat striatum, Neurosci. Lett., 117, 248, 1990.
159. Guennoun, R. and Bloch, B., Ontogeny of D1 and DARPP-32 gene expression in the rat striatum: an in situ hybridization study, Mol. Brain Res., 12, 131, 1992.
160. Parent, A., Extrinsic connections of the basal ganglia, TINS, 13, 254, 1990.
161. Elde, R., Schalling, M., Ceddatelli, S., Nakanishi, S. and Hokeflt, T., Localization of neuropeptide receptor mRNA in rat brain: initial observations using probes for neurotensin and substance P receptors, Neurosci. Lett., 120, 134, 1990.
162. Gerfen C. R., Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain, Brain Res., 556, 165, 1991.
163. Maeno, H., Kiyama, H. and Tohyama, M., Distribution of the substance P receptor (NK1-receptor) in the central nervous system, Mol. Brain Res., 18, 43, 1993.
164. Le Moine, C. B., Kieffer, C., Gaveriaux-Ruff, K. B. and Bloch, B., Delta-opioid receptor gene expression in the mouse striatum: Localization in cholinergic neurons of the striatum, Neuroscience, 62, 635, 1994.
165. Mansour, A., Thompson, R. C., Akil, H. and Watson, S. J., Delta opioid receptor mRNA distribution in the brain: comparison to delta receptor binding and proenkephalin mRNA, J. Chem. Neuroanat., 6, 351, 1993.
166. Pickel, V. M. and Chan, J., Spiny neurons lacking choline acetyltransferase immu-noreactivity are major targets of cholinergic and catecholaminergic terminals in rat striatum, J. Neurosci. Res., 25, 263, 1990.
167. Chang, H. T. and Kita, H., Interneurons in the rat striatum: relationships between parvalbumin neurons and cholinergic neurons, Brain Res., 574, 307, 1992.
168. Vuillet, J., Dimova, R., Nieoullon, A. and Kerkerian-Le Goff, L., Ultrastructural relationships between choline acetyltransferase- and neuropeptide Y-containing neurons in the rat striatum, Neuroscience, 46, 351, 1992.
169. Wilson, C. J., Chang, H. T. and Kitai, S. T., Firing patterns and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum, J. Neurosci., 10, 508, 1990.
170. Akaike, A., Sasa, M. and Takaori, S., Muscarinic inhibition as a dominant role in cholinergic regulation of transmission in the caudate nucleus,]. Pharmacol Exper. Thera., 246, 1129, 1988.
171. Bernard, V., Normand, E. and Bloch, B., Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor gene, J. Neurosci., 12, 3591, 1992.
172. Weiner, D. M., Levey, A. and Brann, M. R., Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia, Proc. Natl. Acad. Sci. U.S.A., 87, 7050, 1990.
173. Hulme, E. C, Birdsall, N. J. M. and Buckley, N. J., Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol., 30, 633, 1990.
174. McKinney, M., Muscarinic receptor subtype-specific coupling to second messengers in neuronal systems, Prog. Brain Res., 98, 333, 1993.
175. Hagan, J. J., Tonnaer, J. A. D. M., Rijk, H., Broekkamp, C. L. E. and van Delft, A. M. L., Facilitation of amphetamine-induced rotation by muscarinic antagonists is correlated with M2 receptor affinity, Brain Res., 410, 69, 1987.
176. Shannon, H.E. and Peters, S. C, A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice, J. Pharmacol. Exp. Ther., 255, 549, 1990.
177. Arnfred, T. and Randrup, A., Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behavior, Acta Pharmacol. Toxicol., 26, 384, 1968.
178. Bymaster, F. P, Heath, I., Hendrix, J. C. and Shannon, H. E., Comparative behavioral and neurochemical activities of cholinergic antagonists in rats, J. Pharmacol. Exp. Ther., 267, 16, 1993.
179. Butkerait, P. and Friedman, E., Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390, Eur. J. Pharmacol, 148, 269, 1988.
180. Ohmori, T., Abekawa, T. and Koyama, T., Scopolamine prevents the development of sensitization to methamphetamine, Life Sci., 56, 1223, 1995.
181. Yui, K., Miura, T., Sugiyama, K., Ono, M. and Nagase, M., Methamphetamine plus scopolamine potentiates behavioral sensitization and conditioning, Eur. J. Pharmacol, 279, 135, 1995.
182. 2 receptor antagonists on acetylcholine levels in the rat striatum, Eur. J. Pharmacol., 129, 359, 1986.
183. 2 dopamine receptors in rat striatum under freely moving conditions, Brain Res., 518, 193, 1990.
184. 2 dopaminergic regulation of acetylcholine release from striata of freely moving rats, J. Neurochem., 54, 2145, 1990.
185. Damsma, G., Tham, C. S., Robertson, G. S. and Fibiger, H. C, Dopamine D receptor stimulation increases striatal acetylcholine release in the rat, Eur. J. Pharmacol., 186, 335, 1990.
186. Damsma, G., Robertson, G. S., Tham, C. S. and Fibiger, H. C, Dopaminergic regulation of striatal cholinergic release: importance of D1 and N-methyl-DM-aspar-tate receptors, /. Pharmacol. Exp. Ther., 259, 1064, 1991.
187. 2 dopamine receptors and the regulation of striatal acetylcholine release in vivo, Prog. Brain Res., 98, 201, 1993.
188. 2 regulation of in vivo ACH release from striatum, J. Neurochem., 59, 353, 1992.
189. Russi, G., Cadoni, C., Di Chiara, G. and Consolo, S., Neuroleptics increase striatal acetylcholine release by a sequential D-l and D-2 receptor mechanism, NeuroReport, 4, 1335, 1993.
190. Florin, S. M., Kuczenski, R. and Segal, D. S., Amphetamine-induced changes in behavior and caudate extracellular acetylcholine, Brain Res., 581, 53, 1992.
191. Lindefors, N., Hurd, Y. L., O'Connor, W. T., Brene, S., Persson, H. and Ungerstedt, U., Amphetamine regulation of acetylcholine and y-aminobutyric acid in nucleus accumbens, Neuroscience, 48, 439, 1992.
192. Acquas, E. and Fibiger, H. C., Concentration dependent effects of neostigmine on d-amphetamine induced increases in striatal acetylcholine release, Abstr. Soc. Neurosci., 21, 2137, 1995.
193. DeBoer, R and Abercrombie, E. D., Physiological release of striatal acetylcholine in vivo: modulation by DI and D2 dopamine receptor subtypes, J. Pharmacol. Exp. Ther., in press.
194. DeBoer, P. and Abercrombie, E. D., Further characterization of the role of substantia nigra in the modulation of striatal acetylcholine in awake rats, Abstr. Soc. Neurosci., 20, 285, 1994.
195. Furmidge, L. J., Duggan, A. W. and Arbuthnott, G. W., Substance P release from rat nucleus accumbens and striatum: an in vivo study using antibody microprobes, Brain Res., 610, 234, 1993.
196. Anderson, J. J., Chase, T. N. and Engber, T. M., Substance P increases release of acetylcholine in the dorsal striatum of freely moving rats, Brain Res., 623,189,1993.
197. 2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum, J. Pharmacol. Exp. Ther., 274, 928, 1995.
198. Arenas, E., Alberch, J., Perez-Navarro, E., Solsona, C. and Marsal, J., Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by ta-chykinins in the neostriatum, J. Neurosci., 11, 2332, 1991.
199. Petitet, F., Glowinski, J. and Beaujouan, J. C., Evoked release of acetylcholine in the rat striatum by stimulation of tachykinin NK-1 receptors, Eur. J. Pharmacol., 192, 203, 1991.
200. Cameron, D. L. and Williams, J. T., Dopamine DI receptors facilitate transmitter release, Nature, 366, 344, 1993.
201. Baldi, G., Russi, G., Nannini, L., Vezzani, A. and Consolo, S., Trans-synaptic modulation of striatal ACH release in vivo by the parafascicular thalamic nucleus, Eur. J. Neurosci., 7, 1117, 1995.
202. Anderson, J. J., Kuo, S. and Chase, T. N., Endogenous excitatory amino acids tonically stimulate striatal acetylcholine release through NMDA but not AMPA receptors, Neurosci. Lett., 176, 264, 1994.
203. Giovannini, M. G., Camilli, F., Mundula, A. and Pepeu, G., Glutamatergic regulation of acetylcholine output in different brain regions: a microdialysis study in the rat, Neurochem. Int., 25, 23, 1994.
204. Zocchi, A. and Pert, A., Alterations in striatal acetylcholine overflow by cocaine, morphine, and MK-801: relationship to locomotor output, Psychopharmacology, 115, 297, 1994.
205. Bernard, V., Dumartin, B., Lamy, E. and Bloch, B., Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat, Eur. J. Neurosci., 5, 1218, 1993.
206. Wang J. Q. and McGinty, J. F., Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats, Neuroscience, in press.
207. 1 dopamine receptor agonist SKF-82958 in the intact rat striatum, Neuroscience, 72, 601, 1996.
208. Wang J. Q. and McGinty, J. F., Full D1 dopamine receptor agonist SKF 82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 synergy by muscarinic receptors, submitted.
209. 2 mediated responses, Neuroscience, 53, 673, 1993.
210. R) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression, Neuroscience, 66, 37, 1995.
211. Di Chiara, G. and Morelli, M., Dopamine-acetylcholine-glutamate interactions in the striatum, Adv. Neurol, 60, 102, 1993.
212. Hyman, S. E., Cole, R. L., Konradi, C. and Kosofsky, B. E., Dopamine regulation of transcription factor-target interactions in rat striatum, Chem. Senses, 20, 257, 1995.
213. 2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons, Mol Brain Res., 13, 35, 1992.
214. Guo, N., Robertson, G. S. and Fibiger, H. C., Scopolamine attenuates haloperidol-induced c-fos expression in the striatum, Brain Res., 588, 164, 1992.
215. Mulder, A. H., Wardeh, G., Hogenboom, F. and Frankhuyzen, A. L., k- and 6-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release, Nature, 308, 278, 1984.
216. Steiner, H., Mariotti, R. and Gerfen, C. R., Enkephalin inhibits immediate early gene expression induced by blockade of D2 dopamine receptors in striatum, Abstr. Soc. Neurosci., 21, 1904, 1995.
217. 2 dopamine receptor activation, Synapse, 18, 233, 1994.
218. Cole, R. L., Konradi, C., Douglass, J. and Hyman, S. E., Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum, Neuron, 14, 813, 1995.
219. Blackburn, J. R., Chapman, C. A., Blaha, C. D. and Yeomans, J. S., Striatal dopamine levels increase following peripheral scopolamine injections and following application of scopolamine to the tegmental pedunculopontine nucleus, Abstr. Neurosci. Soc., 20, 1559, 1994.
220. Dewey, S. L., Smith, G. S., Logan, J., Brodie, J. D., Simkowitz, R, MacGregor, R. R., Fowler, J. S., Volkow, N. D. and Wolf, A. P., Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal and human subjects, Proc. Natl. Acad. Sci. U.S.A., 90, 11816, 1993.
221. Hsu, K. S., Huang, C. C. and Gean, P. W., Muscarinic depression of excitatory synaptic transmission mediated by the presynaptic M3 receptors in the rat neostriatum, Neurosci. Lett., 197, 141, 1995.
222. Sugita, S., Uchimura, N., Jiang, Z. G. and North, R. A., Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain, Proc. Natl. Acad. Sci. U.S.A., 88, 2608, 1991.
223. 2 receptor agonists, Neuroscience, 63, 427, 1994.
224. Spanagel, R., Herz, A. and Shippenberg, T. S., Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway, Proc. Natl. Acad. Sci. U.S.A., 89, 2046, 1992.
225. Maisonneuve, I. M., Archer, S. and Glick, S. D., U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats, Neurosci. Lett., 181, 57, 1994.
226. Heidbreder, C. A., Goldberg, S. R. and Shipperberg, T. S., The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat, Brain Res., 616, 335, 1993.